SCHEDULE: Neil Gagnon and Affiliates Disclose 5.2% Stake in CareDx, Inc.

Neil Gagnon, along with Gagnon Securities LLC and Gagnon Advisors, LLC, has reported a combined beneficial ownership of 5.2% in CareDx, Inc. common stock.

Summary

• Neil Gagnon, Gagnon Securities LLC, and Gagnon Advisors, LLC have jointly filed a Schedule 13G detailing their beneficial ownership in CareDx, Inc.
• Neil Gagnon individually beneficially owns 2,894,541 shares of CareDx, Inc. common stock, representing 5.2% of the class.
• Gagnon Securities LLC beneficially owns 2,134,124 shares, accounting for 3.8% of the class.
• Gagnon Advisors, LLC beneficially owns 462,852 shares, representing 0.8% of the class.
• Neil Gagnon holds sole voting and dispositive power over 170,357 shares and shared voting power over 2,396,593 shares, and shared dispositive power over 2,724,184 shares.
• Gagnon Securities LLC, a registered investment adviser and broker-dealer, has shared voting power over 1,815,773 shares and shared dispositive power over 2,134,124 shares.
• Gagnon Advisors, LLC, a registered investment adviser, has shared voting and dispositive power over 462,852 shares.
• The reporting persons explicitly disclaim beneficial ownership of securities held in managed accounts, except to the extent of their shared powers.
• The filing certifies that the securities were not acquired and are not held for the purpose of changing or influencing the control of CareDx, Inc.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or prospects.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• The disclosure of a significant stake by an individual investor and associated entities may be viewed positively by some shareholders as a vote of confidence, while others may monitor for potential future activism, though the filing disclaims intent to influence control.

Key Dates

Keywords

CareDx Inc., CDNA, Schedule 13G, beneficial ownership, institutional investor, investment adviser, broker-dealer, Neil Gagnon, Gagnon Securities, Gagnon Advisors, common stock, equity stake